Targeted and exome sequencing identified somatic mutations in hepatocellular carcinoma
- 15 March 2016
- journal article
- research article
- Published by Wiley in Hepatology Research
- Vol. 46 (11), 1145-1151
- https://doi.org/10.1111/hepr.12663
Abstract
AimGenetic analysis has revealed a subset of recurrently mutated genes and aberrant cellular signaling pathways in hepatocellular carcinoma. To investigate genetic alterations and dysregulated pathways in hepatocellular carcinoma, we performed targeted sequencing and exome analysis using next-generation sequencer. MethodsWe analyzed the somatic mutational profiles of 16 genes in primary hepatocellular carcinoma by targeted ultra-deep sequencing using nine pairs of specimens (tumor and peripheral blood) and whole-exome sequencing using one pair of samples. ResultsOverall, somatic mutations with high allele fraction were identified in tumor tissues by targeted deep sequencing. Somatic mutations with high allele fraction were observed in TP53 (3/9; 33%) and CTNNB1 (2/9; 22%) genes in five out of nine (55%) specimens. In vitro analysis showed that CTNNB1 H36P mutant protein identified in tumor samples was resistant to protein degradation and promoted cell proliferation. Exome sequencing identified SLIT3 mutation, implying that dysregulation of axon guidance genes is involved in the development of hepatocellular carcinoma. These results showed that TP53 and WNT/-catenin signaling pathways were commonly mutated in hepatocellular carcinoma. ConclusionThese results suggest that targeted sequencing and exome sequencing enable the identification of putative oncogenic driver mutations during the development of hepatocarcinoma.Keywords
Funding Information
- National Natural Science Foundation of China (81370505)
This publication has 33 references indexed in Scilit:
- Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinomaGenome Research, 2013
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genesNature, 2012
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- The many faces and functions of β-cateninThe EMBO Journal, 2012
- Genomics in hepatocellular carcinoma—a big step forwardNature Reviews Gastroenterology & Hepatology, 2012
- Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinomaNature Genetics, 2011
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- The IARC TP53 database: New online mutation analysis and recommendations to usersHuman Mutation, 2002